Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2014. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction notification and does not contain financial performance data.
Material Changes
The filing reports a specific transaction on April 10, 2014, where Mrs. K Thomson (Connected Person to Director Mr. P C Thomson) acquired 15 Ordinary Shares. The acquisition occurred at a price of 1585.037 pence per share through the reinvestment of dividends under the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of a share purchase.
Key Facts for Investor Verification
- Transaction Date: April 10, 2014
- Connected Person: Mrs. K Thomson (spouse of Director Mr. P C Thomson)
- Shares Acquired: 15 Ordinary Shares
- Price per Share: 1585.037 pence
- Transaction Method: Dividend reinvestment via the ShareReward Plan
- Notification Date: April 11, 2014